English
SpanishTrusted Resources: People & Places
Healthcare providers, researchers, and advocates
The mission of the SMA Foundation is to accelerate the development of treatments for Spinal Muscular Atrophy. SMA is the leading genetic cause of death in young children. The SMA Foundation was established in 2003 by Loren Eng and Dinakar Singh, parents of a child with SMA.
BookmarkRelated Content
-
Natural History of Spinal Muscular Atrophy in Children: An Analysis of 117 CasesObjectives: To study the natural history...
-
Your Guide to Spinal Muscular Atrophyhttps://simedhealth.com/sites/default/fi...
-
Coverage of Genetic Therapies for Spinal Muscular Atrophy Across Fee-for-Service Medicaid ProgramsBackground: Genetic therapies are a prom...
-
Implications of Circulating Neurofilaments for Spinal Muscular Atrophy Treatment Early In Life: A Case SeriesThis longitudinal cohort study aimed to ...
-
Pharmacological and Clinical Profile of Onasemnogene Aveparvovec, the First Gene Therapy for Spinal Muscular Atrophy...Onasemnogene abeparvovec (Zolgensma; for...
-
Improvement in Fine Manual Dexterity in Children With Spinal Muscular Atrophy Type 2 After Nusinersen Injection: A C...Although nusinersen has been demonstrate...
-
The Gwendolyn Strong FoundationAt Gwendolyn Strong Foundation, we work ...
